• Affordable Educational Credits
  • Watch At Your Convenience
  • Worldwide Speakers
  • Captivating Topics
  • Peer Interactions

GOLD Learning Speakers


Andrew Shennan, OBE, MBBS, FROCG, MD

  • Speaker Type: GOLD Obstetrics 2019
  • Country: UK

Andrew Shennan is Professor of Obstetrics at King’s College London, based at St. Thomas’ Hospital and is Clinical Director of South London Clinical Research Network. He sits on the UK HTA commissioning board.

He specialises in clinical trials in antenatal and intrapartum care. His research interests include interventions to predict and prevent preterm birth, pre-eclampsia, global health and the use of blood pressure monitoring. He has published over 500 peer reviewed research reports (H index >45 RG score >50). Current research funding as applicant/co applicant is £32 million in 17 grants.

He has an active clinical role in managing high risk obstetric patients, including a regular hands-on labour ward commitment, and a specialist preterm birth surveillance clinic (award winning 2013/2015/2016 innovations prize) that accepts national and international referrals. He is the recipient of the international 2017 Newton Prize (£200,000) for excellence in research and innovation in support of economic development and social welfare in low and middle-income countries. He was awarded an OBE in 2018 for services to maternity care.

CE Library Presentation(s) Available Online:
Watch Today!
View Lecture
Note: Currently only available through a bundled series of lectures
Advances in Managing Pre-eclampsia: A Global Imperative
The management of pre-eclampsia is based around accurate detection of risk, targetting of prophylactic therapies and then prompt intervention. Most deaths occur in low and middle income countries, but when well mananged maternal deaths are very rare. The judicous use of prophylactic aspirin, and the subsequent detection of those at risk are key to success. This allows timely delivery while managing women in a safe environment with prompt access to anti hypertensive medication and anticonvulsants such as Magnesium Sulphate. This talk will discuss the evidence base around new angiogenic markers to identify risk, the use of aspirin and the need for effective monitoring in a global setting. The role of early delivery will also be elucidated.
Hours / CE Credits: (details)  |  Categories: Midwifery